Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04054557 · ClinicalTrials.gov registry record · NA
Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence
A NA study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 305
- Enrollment target
NCT04054557 is a NA study that has completed, run by Thomas Jefferson University. The registered enrollment target is 305 participants.
The verdict
NCT04054557, a NA study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 305 participants
- Enrollment target
Study Summary
This phase II trial studies how well telehealth works in improving adherence to endocrine (anti-estrogen) therapy in participants with estrogen receptor and/or progesterone receptor positive (hormone receptor positive) stage 0-III breast cancer who have underwent surgery. Telehealth is an approach to care that uses digital information and communication tools to manage health and well-being. Participants interact with their health care providers via a video chat on a computer or smart phone. Telehealth may help identify the effects of treatment on participants with breast cancer who have underwent surgery.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Survey Administration
- OTHER Questionnaire Administration
- OTHER Best Practice
- OTHER Telemedicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 305 participants |
| Start Date | 2019-07-31 |
| Est. Completion | 2024-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04054557
The ClinicalTrials.gov registry entry for NCT04054557 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04054557 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04054557 about?
NCT04054557 is a clinical study titled "Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence". This phase II trial studies how well telehealth works in improving adherence to endocrine (anti-estrogen) therapy in participants with estrogen receptor and/or progesterone receptor positive (hormone receptor positive) stage 0-III breast cancer who have underwent surgery. Telehealth is an approach t...
What is the current status of trial NCT04054557?
This trial is currently completed. It is a NA study. The enrollment target is 305 participants. The study started on 2019-07-31. Estimated completion is 2024-12-06.
What interventions are being tested in trial NCT04054557?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Survey Administration (OTHER), Questionnaire Administration (OTHER), Best Practice (OTHER), Telemedicine (OTHER).
Who is sponsoring clinical trial NCT04054557?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.